Barclays PLC 908 Devices Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in 908 Devices Inc. stock. As of the latest transaction made, Barclays PLC holds 44,128 shares of MASS stock, worth $171,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,128

Previous 46,214 4.51%

Holding current value

$171,216

Previous $160,000 39.38%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.88 - $3.91 $3,921 - $8,156	-2,086 Reduced 4.51%	44,128 $97,000
Q3 2024 Nov 15, 2024	BUY	$3.45 - $6.17 $130,592 - $233,553	37,853 Added 452.73%	46,214 $160,000
Q2 2024 Aug 14, 2024	SELL	$5.0 - $7.24 $36,035 - $52,178	-7,207 Reduced 46.29%	8,361 $43,000
Q1 2024 May 15, 2024	SELL	$6.55 - $9.92 $95,269 - $144,286	-14,545 Reduced 48.3%	15,568 $117,000
Q4 2023 Feb 15, 2024	BUY	$4.96 - $12.41 $130,304 - $326,023	26,271 Added 683.78%	30,113 $338,000
Q3 2023 Nov 07, 2023	SELL	$6.0 - $8.2 $4,020 - $5,493	-670 Reduced 14.85%	3,842 $25,000
Q2 2023 Aug 03, 2023	SELL	$5.78 - $10.02 $38,477 - $66,703	-6,657 Reduced 59.6%	4,512 $31,000
Q1 2023 May 04, 2023	BUY	$6.61 - $10.66 $32,937 - $53,118	4,983 Added 80.55%	11,169 $96,000
Q4 2022 Feb 13, 2023	BUY	$7.0 - $17.96 $36,813 - $94,451	5,259 Added 567.31%	6,186 $47,000
Q3 2022 Nov 03, 2022	SELL	$15.18 - $24.99 $2,595 - $4,273	-171 Reduced 15.57%	927 $15,000
Q2 2022 Aug 12, 2022	SELL	$13.3 - $20.74 $33,835 - $52,762	-2,544 Reduced 69.85%	1,098 $23,000
Q1 2022 May 16, 2022	BUY	$13.18 - $26.28 $48,001 - $95,711	3,642 New	3,642 $69,000

Others Institutions Holding MASS

# of Institutions

Shares Held

16.7M

Call Options Held

500

Put Options Held

29.9K

View Full List

About 908 Devices Inc.

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $123M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

More about MASS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account